Want to join the conversation?
Gypsum wallboard and cement maker $EXP reported a rise in 1Q17 earnings driven by higher performance in its construction products and building materials businesses. Net income rose to $45.34MM or $0.93 per share from $37.76MM or $0.75 per share last year. Revenues grew to $297.5MM from $284.96MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?